Visit Us @
Synergy Centre TU Dublin, Tallaght, D24A386
Mail Us @
info@codlad.com
Call Us @
+353 851890752

News

FDA Advances Data, IT Modernization Efforts with New Office of Digital Transformation

September 15, 2021

FDA Advances Data, IT Modernization Efforts with New Office of Digital Transformation

Today, the U.S. Food and Drug Administration announced the reorganization of the agency’s information technology (IT), data management and cybersecurity functions into the new Office…

FDA Advances Data, IT Modernization Efforts with New Office of Digital Transformation FDA
FDA In Brief: FDA Announces Winners of Food Traceability Challenge

September 13, 2021

FDA In Brief: FDA Announces Winners of Food Traceability Challenge

The following quote is attributed to Frank Yiannas, Deputy Commissioner for Food Policy and Response “In June, we launched the New Era of Smarter Food…

FDA In Brief: FDA Announces Winners of Food Traceability Challenge FDA
Coronavirus (COVID-19) Update: September 10, 2021

September 10, 2021

Coronavirus (COVID-19) Update: September 10, 2021

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Today, the FDA posted…

Coronavirus (COVID-19) Update: September 10, 2021 FDA
FDA Will Follow The Science On COVID-19 Vaccines For Young Children

September 10, 2021

FDA Will Follow The Science On COVID-19 Vaccines For Young Children

As schools around the country are re-opening for in-person learning and families are returning to their busy school year schedules, we know many parents are…

FDA Will Follow The Science On COVID-19 Vaccines For Young Children FDA
FDA Makes Significant Progress in Science-Based Public Health Application Review, Taking Action on Over 90% of More Than 6.5 Million ‘Deemed’ New Tobacco Products Submitted

September 9, 2021

FDA Makes Significant Progress in Science-Based Public Health Application Review, Taking Action on Over 90% of More Than 6.5 Million ‘Deemed’ New Tobacco Products Submitted

The following is attributed to Acting FDA Commissioner Janet Woodcock, M.D., and Mitch Zeller, J.D., director of the FDA’s Center for Tobacco Products On this…

FDA Makes Significant Progress in Science-Based Public Health Application Review, Taking Action on Over 90% of More Than 6.5 Million ‘Deemed’ New Tobacco Products Submitted FDA
FDA In Brief: As Consumers Order More Meals and Groceries Online, FDA Plans Public Meeting to Address Food Safety Risks

September 9, 2021

FDA In Brief: As Consumers Order More Meals and Groceries Online, FDA Plans Public Meeting to Address Food Safety Risks

The following quote is attributed to Frank Yiannas, Deputy Commissioner for Food Policy and Response “The COVID-19 pandemic has accelerated the need for the FDA…

FDA In Brief: As Consumers Order More Meals and Groceries Online, FDA Plans Public Meeting to Address Food Safety Risks FDA
FDA, FTC Warn 10 Companies Illegally Selling Dietary Supplements Claiming to Treat Diabetes

September 9, 2021

FDA, FTC Warn 10 Companies Illegally Selling Dietary Supplements Claiming to Treat Diabetes

Today, the U.S. Food and Drug Administration and the Federal Trade Commission posted warning letters to 10 companies for illegally selling dietary supplements that claim…

FDA, FTC Warn 10 Companies Illegally Selling Dietary Supplements Claiming to Treat Diabetes FDA
FDA In Brief: FDA Announces Public Workshop to Reconsider Mandatory Prescriber Education for Opioids

September 8, 2021

FDA In Brief: FDA Announces Public Workshop to Reconsider Mandatory Prescriber Education for Opioids

The following quote is attributed to Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research “The opioid crisis continues to evolve…

FDA In Brief: FDA Announces Public Workshop to Reconsider Mandatory Prescriber Education for Opioids FDA
Coronavirus (COVID-19) Update: September 7, 2021

September 7, 2021

Coronavirus (COVID-19) Update: September 7, 2021

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: As part of the…

Coronavirus (COVID-19) Update: September 7, 2021 FDA
FDA In Brief: FDA Reaches Milestone in Competitive Generic Therapy Drug Approvals

September 2, 2021

FDA In Brief: FDA Reaches Milestone in Competitive Generic Therapy Drug Approvals

The following quote is attributed to Sally Choe, Ph.D., director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research…

FDA In Brief: FDA Reaches Milestone in Competitive Generic Therapy Drug Approvals FDA

Latest Posts

FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
March 25, 2026
FDA Schedules Public Meeting on the Commissioner’s National Priority Voucher Pilot Program
FDA Schedules Public Meeting on the Commissioner’s National Priority Voucher Pilot Program
March 20, 2026
FDA Approves Fourth Product Under National Priority Voucher Program, Higher Dose Semaglutide
FDA Approves Fourth Product Under National Priority Voucher Program, Higher Dose Semaglutide
March 19, 2026